⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2011682 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2239385 | 0.98 | EGLN1 (0.57) | — | |
| Hydrochloric Acid SCHEMBL2239390 | 0.98 | EGLN1 (0.57) | — | |
| SCHEMBL8289297 | 0.80 | — | — | |
| SCHEMBL5765192 | 0.78 | EGLN1 (0.45) | — | |
| SCHEMBL30139851 | 0.78 | EGLN1 (0.45) | — | |
| SCHEMBL12330336 | 0.77 | EGLN1 (0.35) | — | |
| SCHEMBL9362483 | 0.76 | CYP2D6 (0.55) | — | |
| SCHEMBL1647486 | 0.75 | KDM4E (0.47) | — | |
| SCHEMBL19844510 | 0.75 | EGLN1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118984715-A | Compositions for the treatment of macular degeneration comprising novel peptides | 韩国视角生物株式会社 | 2024-11-19 | — | — | CN | claimed |
| EP-4450079-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | EyebioKorea, Inc. (KR) | 2024-10-23 | — | — | EP | claimed |
| US-20240228538-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | EYEBIO KOREA (KR) | 2024-07-11 | — | — | US | claimed |
| WO-2023113300-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | 주식회사 아이바이오코리아 | 2023-06-22 | — | — | WO | claimed |
| WO-2020235932-A1 | NOVEL PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 주식회사 아이바이오코리아 (KR) | 2020-11-26 | — | — | WO | claimed |
| US-20170348266-A1 | INHIBITION OF PROLINE CATABOLISM FOR THE TREATMENT OF CANCER AND OTHER THERAPEUTIC APPLICATIONS | BUCK INSTITUTE FOR RESEARCH ON AGING | 2017-12-07 | — | — | US | claimed |
| WO-2016077632-A2 | INHIBITION OF PROLINE CATABOLISM FOR THE TREATMENT OF CANCER AND OTHER THERAPEUTIC APPLICATIONS | BUCK INSTITUTE FOR RESEARCH ON AGING (US) | 2016-05-19 | — | — | WO | claimed |
| CN-1178788-A | Angiotensin invertase inhibitor contaiing 2 ,4 -methylene proline and its sythesis and use | SHANGHAI INST ORGANIC CHEM (CN) | 1998-04-15 | — | — | CN | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-4535102-A | CARBOXYLIC MONOMER WITH UNSATURATED ESTER OR OTHER VINYL COMPOUND AND ORGANIC TITANATE AND INITIATOR | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1985-08-13 | — | — | US | claimed |
| US-12428446-B2 | Peptide compound or pharmaceutically acceptable salt thereof | EYEBIO KOREA (KR) | 2025-09-30 | — | — | US | disclosed |
| CN-119968211-A | Clostridium neurotoxin for treating bladder pain syndrome | 益普生生物制药有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4483959-A2 | NOVEL PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EYEBIO KOREA (KR) | 2025-01-01 | — | — | EP | disclosed |
| CN-119234152-A | Scoring method for anti-fra antibody-drug conjugate therapy | 阿斯利康(瑞典)有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119137279-A | Combination therapy | IP2IPO创新有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-4535102-A | CARBOXYLIC MONOMER WITH UNSATURATED ESTER OR OTHER VINYL COMPOUND AND ORGANIC TITANATE AND INITIATOR | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1985-08-13 | — | — | US | disclosed |
| US-4533701-A | MIXTURE OF ADDITION COPOLYMER BASED ON A HYDROPHOBIC MONOMER AND DDICARBOXYLIC ACID AND AN ORGANIC TITANATE; DENTISTRY | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1985-08-06 | — | — | US | disclosed |
| EP-0103420-A2 | Adhesive coating material | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1984-03-21 | — | — | EP | disclosed |
| US-4377701-A | 4-Methylene-1-[[(alranoyl or arylcarbonyl)mercapto]acyl]proline and pipecolic acid | E. R. SQUIBB & SONS, INC. (US) | 1983-03-22 | — | — | US | disclosed |
| EP-0048159-A2 | Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents | UNIVERSITY OF MIAMI (US) | 1982-03-24 | — | — | EP | disclosed |